A detailed history of Qtron Investments LLC transactions in Dexcom Inc stock. As of the latest transaction made, Qtron Investments LLC holds 7,553 shares of DXCM stock, worth $498,498. This represents 0.13% of its overall portfolio holdings.

Number of Shares
7,553
Previous 6,015 25.57%
Holding current value
$498,498
Previous $834,000 2.64%
% of portfolio
0.13%
Previous 0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$110.31 - $140.45 $169,656 - $216,012
1,538 Added 25.57%
7,553 $856,000
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $454,072 - $746,822
6,015 New
6,015 $746,000
Q2 2023

Aug 10, 2023

BUY
$112.47 - $130.98 $192,436 - $224,106
1,711 Added 83.22%
3,767 $484,000
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $174,718 - $252,209
2,056 New
2,056 $232,000
Q2 2020

Aug 13, 2020

SELL
$62.68 - $105.34 $49,015 - $82,375
-782 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $37,371 - $59,142
782 New
782 $211,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Qtron Investments LLC Portfolio

Follow Qtron Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtron Investments LLC with notifications on news.